ArticleClinical and experimental immunology2025

Pirfenidone alleviates interstitial lung disease in mice by inhibiting neutrophil extracellular trap formation and NLRP3 inflammasome activation.

Qiyan Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.